Surface Oncology Inc. (SURF) NASDAQ

$5.12 -0.12 (-2.29%)

Market Cap: $241.75M

As of 12/06/21 04:00 PM EST. Market closed.

(SURF)

Surface Oncology Inc. (SURF) NASDAQ

$5.12 -0.12 (-2.29%)

Market Cap: $241.75M

As of 12/06/21 04:00 PM EST. Market closed.

Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline includes two wholly-owned clinical-stage programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting regulatory T cells via targeting CCR8 (SRF114). In addition, Surface has two partnerships with major ... read more

Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline includes two wholly-owned clinical-stage programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting regulatory T cells via targeting CCR8 (SRF114). In addition, Surface has two partnerships with major pharmaceutical companies: a collaboration with Novartis targeting CD73 (NZV930; Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813; preclinical). Surface's novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response and may be used alone or in combination with other therapies. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
J. Jeffrey Goater
Full Time Employees
51
CEO Compensation (Base)
$429,000
CEO Compensation (Total)
$4.74M
URL
Address
50 Hampshire St Fl 8, Massachusetts, Cambridge, 02139-1548.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
J. Jeffrey Goater
Full Time Employees
51
CEO Compensation (Base)
$429,000
CEO Compensation (Total)
$4.74M
Address
50 Hampshire St Fl 8, Massachusetts, Cambridge, 02139-1548.
KEY STATS
Open
$5.25
Previous Close
$5.24
Days Range
$5.18 - $5.64
52 week range
$4.95 - $14.40
Volume
919,426
Avg. Volume (30 days)
584,342
Market Cap
$241.75M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
46,135,245
Open
$5.25
Previous Close
$5.24
Days Range
$5.18 - $5.64
52 week range
$4.95 - $14.40
Volume
919,426
Avg. Volume (30 days)
584,342
Market Cap
$241.75M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
46,135,245

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SURFACE ONCOLOGY INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
ROSS ROBERT W. Chief Medical Officer Feb 16, 2021 Sale $11.35 1,000 11,350 88,000 Feb 18, 2021, 08:00 PM
FEES JESSICA See Remarks Feb 08, 2021 Sale $12.45 1,500 18,675 99,183 Feb 09, 2021, 08:00 PM
Goater Jeff Chief Executive Officer Feb 08, 2021 Option Exercise $3.18 2,500 7,950 264,500 Feb 09, 2021, 08:00 PM
Goater Jeff Chief Executive Officer Feb 08, 2021 Sale $12.50 2,500 31,250 262,000 Feb 09, 2021, 08:00 PM
Goater Jeff Chief Executive Officer Feb 01, 2021 Option Exercise $3.18 2,500 7,950 264,500 Feb 03, 2021, 08:00 PM
Goater Jeff Chief Executive Officer Feb 01, 2021 Sale $10.69 2,500 26,718 262,000 Feb 03, 2021, 08:00 PM
FEES JESSICA See Remarks Feb 01, 2021 Sale $11.19 1,500 16,785 100,683 Feb 03, 2021, 08:00 PM
Goater Jeff Chief Executive Officer Jan 19, 2021 Option Exercise $3.18 5,000 15,900 267,000 Jan 21, 2021, 08:17 PM
Goater Jeff Chief Executive Officer Jan 19, 2021 Sale $13.00 5,000 65,000 262,000 Jan 21, 2021, 08:17 PM
ROSS ROBERT W. Chief Medical Officer Jan 15, 2021 Sale $12.25 2,000 24,500 89,000 Jan 15, 2021, 08:00 PM
ROSS ROBERT W. Chief Medical Officer Jan 14, 2021 Sale $11.95 7,000 83,650 91,000 Jan 15, 2021, 08:00 PM
GRAYZEL DAVID S. Director Dec 17, 2020 Sale $8.10 1,700,000 13,770,001 2,945,453 Dec 21, 2020, 03:35 PM
Atlas Venture Fund IX, L.P. 10% Owner Dec 17, 2020 Sale $8.10 1,700,000 13,770,001 2,945,453 Dec 21, 2020, 03:35 PM
GRAYZEL DAVID S. Director Dec 17, 2020 Sale $18.10 1,700,000 30,770,001 2,945,453 Dec 21, 2020, 01:32 PM
Atlas Venture Fund IX, L.P. 10% Owner Dec 17, 2020 Sale $18.10 1,700,000 30,770,001 2,945,453 Dec 21, 2020, 01:32 PM
ROSS ROBERT W. Chief Medical Officer Dec 15, 2020 Sale $10.48 1,000 10,480 98,000 Dec 17, 2020, 08:00 PM
ROSS ROBERT W. Chief Medical Officer Dec 11, 2020 Sale $10.05 1,405 14,120 99,000 Dec 15, 2020, 08:00 PM
FEES JESSICA See Remarks Nov 25, 2020 Option Exercise $5.06 1,383 6,996 102,183 Nov 27, 2020, 08:00 PM
ROSS ROBERT W. Chief Medical Officer Nov 11, 2020 Sale $10.05 595 5,980 100,405 Nov 13, 2020, 08:00 PM
FEES JESSICA See Remarks Oct 28, 2020 Option Exercise $4.14 4,895 20,262 100,800 Oct 30, 2020, 08:30 PM
ROSS ROBERT W. Chief Medical Officer Oct 14, 2020 Sale $10.05 4,000 40,200 101,000 Oct 16, 2020, 08:02 PM
EcoR1 Capital, LLC 10% Owner Sep 01, 2020 Sale $7.14 332,780 2,376,682 4,701,081 Sep 03, 2020, 04:17 PM
New Enterprise Associates 14, L.P. 10% Owner May 20, 2020 Sale $3.66 420,000 1,535,562 2,892,877 May 22, 2020, 04:56 PM
Dwyer Wendy Chief Business Officer Feb 28, 2020 Option Exercise $1.70 5,000 8,500 85,000 Mar 03, 2020, 04:05 PM
Goater Jeff Chief Executive Officer Feb 05, 2020 Buy $3.23 5,000 16,150 262,000 Feb 07, 2020, 04:05 PM
FEES JESSICA See Remarks Apr 01, 2019 Option Exercise $0.35 2,728 960 50,905 Apr 02, 2019, 07:00 PM
ROSS ROBERT W. Chief Medical Officer Jan 04, 2019 Option Exercise $4.14 25,000 103,400 25,000 Jan 08, 2019, 04:05 PM
FEES JESSICA See Remarks Jan 04, 2019 Option Exercise $1.11 2,273 2,522 48,177 Jan 08, 2019, 04:05 PM
Viswanathan Ravi 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:48 PM
Sonsini Peter W. 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:48 PM
SANDELL SCOTT D 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:47 PM
MOTT DAVID M 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:47 PM
KERINS PATRICK J 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:47 PM
Florence Anthony A. Jr. 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:46 PM
BASKETT FOREST 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:46 PM
BARRIS PETER J 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:45 PM
BARRETT M JAMES 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:45 PM
New Enterprise Associates 14, L.P. 10% Owner Apr 23, 2018 Buy $15.00 133,333 1,999,995 3,312,877 Apr 23, 2018, 04:45 PM
Novartis Institutes for BioMedical Research, Inc. 10% Owner Apr 23, 2018 Buy $15.00 766,666 11,499,990 3,948,482 Apr 23, 2018, 04:43 PM
Atlas Venture Fund IX, L.P. 10% Owner Apr 23, 2018 Buy $15.00 100,000 1,500,000 4,645,453 Apr 23, 2018, 04:18 PM
GRAYZEL DAVID S. Director Apr 23, 2018 Buy $15.00 100,000 1,500,000 4,645,453 Apr 23, 2018, 04:18 PM
LV Management Group, LLC 10% Owner Apr 23, 2018 Buy $15.00 266,000 3,990,000 3,447,817 Apr 23, 2018, 04:16 PM
Shanafelt Armen Director Apr 23, 2018 Buy $15.00 266,000 3,990,000 3,447,817 Apr 23, 2018, 04:16 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
ROSS ROBERT W. Chief Medical Officer 02/16/2021 11,350
FEES JESSICA See Remarks 02/08/2021 18,675
Goater Jeff Chief Executive Officer 02/08/2021 7,950
Goater Jeff Chief Executive Officer 02/08/2021 31,250
Goater Jeff Chief Executive Officer 02/01/2021 7,950
Goater Jeff Chief Executive Officer 02/01/2021 26,718
FEES JESSICA See Remarks 02/01/2021 16,785
Goater Jeff Chief Executive Officer 01/19/2021 15,900
Goater Jeff Chief Executive Officer 01/19/2021 65,000
ROSS ROBERT W. Chief Medical Officer 01/15/2021 24,500
ROSS ROBERT W. Chief Medical Officer 01/14/2021 83,650
GRAYZEL DAVID S. Director 12/17/2020 13,770,001
Atlas Venture Fund IX, L.P. 10% Owner 12/17/2020 13,770,001
GRAYZEL DAVID S. Director 12/17/2020 30,770,001
Atlas Venture Fund IX, L.P. 10% Owner 12/17/2020 30,770,001
ROSS ROBERT W. Chief Medical Officer 12/15/2020 10,480
ROSS ROBERT W. Chief Medical Officer 12/11/2020 14,120
FEES JESSICA See Remarks 11/25/2020 6,996
ROSS ROBERT W. Chief Medical Officer 11/11/2020 5,980
FEES JESSICA See Remarks 10/28/2020 20,262
ROSS ROBERT W. Chief Medical Officer 10/14/2020 40,200
EcoR1 Capital, LLC 10% Owner 09/01/2020 2,376,682
New Enterprise Associates 14, L.P. 10% Owner 05/20/2020 1,535,562
Dwyer Wendy Chief Business Officer 02/28/2020 8,500
Goater Jeff Chief Executive Officer 02/05/2020 16,150
FEES JESSICA See Remarks 04/01/2019 960
ROSS ROBERT W. Chief Medical Officer 01/04/2019 103,400
FEES JESSICA See Remarks 01/04/2019 2,522
Viswanathan Ravi 10% Owner 04/23/2018 1,999,995
Sonsini Peter W. 10% Owner 04/23/2018 1,999,995
SANDELL SCOTT D 10% Owner 04/23/2018 1,999,995
MOTT DAVID M 10% Owner 04/23/2018 1,999,995
KERINS PATRICK J 10% Owner 04/23/2018 1,999,995
Florence Anthony A. Jr. 10% Owner 04/23/2018 1,999,995
BASKETT FOREST 10% Owner 04/23/2018 1,999,995
BARRIS PETER J 10% Owner 04/23/2018 1,999,995
BARRETT M JAMES 10% Owner 04/23/2018 1,999,995
New Enterprise Associates 14, L.P. 10% Owner 04/23/2018 1,999,995
Novartis Institutes for BioMedical Research, Inc. 10% Owner 04/23/2018 11,499,990
Atlas Venture Fund IX, L.P. 10% Owner 04/23/2018 1,500,000
GRAYZEL DAVID S. Director 04/23/2018 1,500,000
LV Management Group, LLC 10% Owner 04/23/2018 3,990,000
Shanafelt Armen Director 04/23/2018 3,990,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
2.06%
1Q
09/30/2021
03/31/2021
4.54%
2Q
09/30/2021
12/31/2020
14.07%
3Q
09/30/2021
09/30/2020
28.64%
4Q
09/30/2021
06/30/2020
28.87%
5Q
09/30/2021
03/31/2020
40.73%
6Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
2.06%
1Q
03/31/2021
4.54%
2Q
12/31/2020
14.07%
3Q
09/30/2020
28.64%
4Q
06/30/2020
28.87%
5Q
03/31/2020
40.73%
6Q
Load More